Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Thermo Fisher Scientific Takes Over Proxeon

Thermo Fisher Scientific has acquired Proxeon, a Denmark-based supplier of products of proteomics analysis, for an undisclosed amount, strengthening its presence in a space in which the company has been looking to expand since 2007.

Proxeon’s nanoflow liquid chromatography system EASY-nLC has been adopted by a number of proteomic centers for its simplicity and ease of use. It features an intuitive graphical user interface, touch-screen operation and remote diagnostics capability.

The compact system footprint includes an autosampler, which allows reproducible low-nanoliter injections into the mass spectrometer, permitting researchers to improve productivity and performance. The system also provides two-dimensional chromatographic capability to identify more proteins than conventional methods, without the increased complexity of added valves and pumps.

Marc Casper, president and chief executive officer of Thermo Fisher Scientific, said: “By offering a high-performance solution that addresses the need for simplified operation, we can meet the increasing demand for LC/MS in proteomics applications. The systems can be easily integrated with our leading ion trap, hybrid and triple quadrupole mass spectrometry systems, in line with our strategy of providing comprehensive LC/MS solutions for both high-end research and routine applications.”

Proxeon offers simplified proteomics workflow, including nanoflow liquid chromatography systems, columns, ion sources, and bioinformatics software, to meet the need for high-sensitivity liquid chromatography/mass spectrometry (LC/MS) analysis in complex proteomics applications.